tert-Butyl 12-bromododecanoate

Catalog No.: 
ACFVRD914
CAS No.: 
172304-05-1
Molecular Formula: 
C16H31BrO2
Molecular Weight: 
335.33
tert-Butyl 12-bromododecanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$143.00In stockIn stock
5g97%$713.00In stockIn stock
25g97%$2848.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 12-bromododecanoate
IUPAC Nametert-butyl 12-bromododecanoate
MDL No.MFCD31728225
Molecular FormulaC16H31BrO2
Molecular Weight335.33
SMILESO=C(OC(C)(C)C)CCCCCCCCCCCBr
InChI KeyJIDZOYCJORLRMY-UHFFFAOYSA-N
Synonymtert-Butyl 12-bromododecanoate;Dodecanoic acid, 12-bromo-, 1,1-dimethylethyl ester
CAS No.172304-05-1
PubChem CID53956741

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFVRD914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTVZG540 route compound structure diagram
    ACTVZG54073367-80-3In Stock
  4. Then
  5. ACFVRD914 route product structure diagram
    ACFVRD914172304-05-1In Stock
Inquiry

2. ACFVRD914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFVRD914 route product structure diagram
    ACFVRD914172304-05-1In Stock
Inquiry

3. ACFVRD914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFVRD914 route product structure diagram
    ACFVRD914172304-05-1In Stock
Inquiry

Comments (0)